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Abstract
Calcium-Response Factor (CaRF) was first identified as a transcription factor based on its affinity for a neuronal-selective
calcium-response element (CaRE1) in the gene encoding Brain-Derived Neurotrophic Factor (BDNF). However, because CaRF
shares no homology with other transcription factors, its properties and gene targets have remained unknown. Here we
show that the DNA binding domain of CaRF has been highly conserved across evolution and that CaRF binds DNA directly
in a sequence-specific manner in the absence of other eukaryotic cofactors. Using a binding site selection screen we identify
a high-affinity consensus CaRF response element (cCaRE) that shares significant homology with the CaRE1 element of Bdnf.
In a genome-wide chromatin immunoprecipitation analysis (ChIP-Seq), we identified 176 sites of CaRF-specific binding
(peaks) in neuronal genomic DNA. 128 of these peaks are within 10kB of an annotated gene, and 60 are within 1kB of an
annotated transcriptional start site. At least 138 of the CaRF peaks contain a common 10-bp motif with strong statistical
similarity to the cCaRE, and we provide evidence predicting that CaRF can bind independently to at least 64.5% of these
motifs in vitro. Analysis of this set of putative CaRF targets suggests the enrichment of genes that regulate intracellular
signaling cascades. Finally we demonstrate that expression of a subset of these target genes is altered in the cortex of Carf
knockout (KO) mice. Together these data strongly support the characterization of CaRF as a unique transcription factor and
provide the first insight into the program of CaRF-regulated transcription in neurons.
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Introduction
The function of any given transcription factor is determined in
large part by its DNA binding specificity, which defines its
potential target genes. Over 1000 gene products are annotated as
transcription factors in the mammalian genome, the vast majority
of which belong to large families classified by the homology of
their DNA binding domains (e.g., homeodomain, zinc finger,
bHLH) [1]. Individual transcription factors within a family often
serve related functions [2] and may compensate at least in part for
the loss of other family members [3]. This redundancy may have
supported the diversification of transcriptional mechanisms
during evolution and the development of increasing organismal
complexity [4].
Some of the most important recent insights into transcription
factor biology have come from the application of technologies that
capture the full complement of transcription factor binding sites
across the genome [5]. By using chromatin immunoprecipitation
followed either by hybridization to tiled genomic microarrays
(ChIP-chip) or high-throughput sequencing (ChIP-Seq) it is
possible to identify a large, unbiased set of transcription factor
binding sites, suggesting candidate target genes [6,7]. Studies of
this kind have been used to reveal unexpected sequence variation
between the individual binding sites selected by a single
transcription factor. Furthermore by elucidating large sets of
potential target genes, these data may suggest new functions for a
transcription factor in previously unanticipated cellular processes
[6,7,8].
Transcription factors are essential for accommodating intracel-
lular states to extracellular stimuli. In the nervous system,
transcription factors play an important role in coordinating
neuronal responses following changes in synaptic activity - a key
stimulus for shaping brain development, driving synaptic plasticity,
and promoting survival of mature neurons [9]. The importance of
this process is highlighted by the fact that mutations in a large
number of transcription factors and transcriptional co-regulators,
including MECP2, FOXP2, CBP, and GTF2I/GTF2IRD1, are
associated with cognitive impairment in humans [10]. Activity-
regulated transcription of the gene encoding the neurotrophin
BDNF is essential for the function of this gene product both in
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10870synaptic plasticity and brain development [11,12], thus substantial
effort has been devoted to understanding the specific mechanisms
that regulate transcription of this gene [13].
Calcium-Response Factor (CaRF) is a novel nuclear protein first
identified as a binding protein for a calcium-response element
(CaRE1) in Bdnf promoter IV [14]. In overexpression assays CaRF
acts as a CaRE1-dependent transcriptional activator, however
other than Bdnf none of CaRF’s target genes are known.
Surprisingly, CaRF shares no sequence similarity with any known
family of transcription factors, and it has no homologs in the
mammalian genome. Given this evidence that CaRF is a unique
transcription factor, we set out to characterize CaRF’s DNA
binding properties and identify its potential target genes that might
in turn suggest biological functions for CaRF beyond Bdnf
regulation.
Here we show that the DNA binding domain of CaRF has been
highly conserved over evolution, and we use both in vitro binding
site selection and genome-scale in vivo chromatin immunoprecip-
itation followed by sequencing (ChIP-Seq) as tools to identify and
characterize high affinity CaRF-binding DNA sequences. These
data reveal a large set of putative CaRF target genes in
mouse cortical neurons, providing the first insight into the CaRF
regulon.
Materials and Methods
Animals
Carf exon 8 KO mice were generated by homologous
recombination [15]. All animal procedures were approved by
the Duke University Institutional Animal Care and Use Commit-
tee. Veterinary care was provided by the staff of the Duke
University Department of Laboratory Animal Research, an
AAALAC accredited facility. Animals were euthanized following
procedures that are in accordance with the recommendations of
the Panel on Euthanasia of the American Veterinary Medical
Association.
Bacterial synthesis of CaRF protein
Full-length mouse CaRF was subcloned in the bacterial
expression vector pThioHisA (Invitrogen, Gaithersburg, MD) at
the EcoRI and XbaI sites. The construct was transformed into
Top10 E. coli and expression of CaRF was induced for 3 hours
with 0.1mM IPTG. Bacteria were lysed by sonication and CaRF
was purified over a ProBond nickel resin column. After washing to
remove unbound protein, binding was competed with 50mM
imidazole to remove nonspecific proteins and then CaRF was
eluted with 250mM imidazole. Fractions containing CaRF as
determined by Western analysis were pooled and concentrated to
a final concentration of 100ng/uL.
Electrophoretic Mobility Shift Assay (EMSA)
EMSAs were performed as described [14] using in vitro
transcribed and translated (TNT) protein (Promega, Madison,
WI) or bacterially expressed CaRF as described above. 2mL TNT
or purified CaRF protein was incubated with 50fmol
32P nick
labeled (Amersham/GE Healthsciences, Piscataway, NJ) or
polynucleotide kinase (New England Biolabs; Ipswitch, MA) end-
labeled annealed oligonucleotide probes prior to separation on 6%
non-denaturing acrylamide gels. In competition assays, unlabeled
probes were added to nuclear extracts in 100-fold molar excess
(unless otherwise noted) to the TNT protein for 30 min. prior to
addition of the radiolabeled probe. Gels were dried and visualized
by phosphorimager (GE Healthsciences). Mobility-retarded bands
were quantified relative to probe intensity in the same lane using
the ImageQuant image analysis program (Molecular Devices,
Sunnyvale, CA). Oligonucleotide probes are listed in Table S1.
Binding site selection screen
PCR-assisted binding site selection was performed essentially as
described [16]. Oligonucleotide sequences and PCR primers used
for the screen are listed in Table S1. Full length human CaRF
(hCaRF) was tagged at its N-terminus with the FLAG-epitope
(GACTACAAGGACGATGACGATAAA) and used for in vitro
TNT as above. For the binding selection, random 16mer
nucleotide sequences were synthesized (IDT DNA, Coralville,
IA) within a 66bp oligo, then made double-stranded by a single
round of PCR using primers against the flanking sequences. Oligos
were incubated with TNT hCaRF or a control TNT master mix
and immunoprecipitated with the M2 anti-FLAG epitope
antibody (Sigma, St. Louis, MO). Coimmunoprecipitated oligos
were purified and amplified by PCR, then used for an additional
three rounds of selection. A subset of the final samples were
radiolabeled and tested by EMSA for their ability to bind hCaRF.
The remaining samples were ligated into pBSK (Stratagene, La
Jolla, CA), the inserts were sequenced and 62 were aligned using
ClustalW (http://www.clustal.org/) [17] to reveal the consensus
CaRF binding motif. The cCaRE logo was generated using the
WebLogo program (http://weblogo.berkeley.edu/) [18].
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation (ChIP) was performed as
described [19]. For CaRF ChIP-Seq, separate cultures of cortical
neurons from newborn Carf
+/+ (WT) or Carf
2/2 (KO) pups were
plated at a density of 10 million cells/10cm dish. 50 million
neurons of each genotype were used for ChIP. Because the Carf
mice are on a mixed C57BL6/129SvJ background, WT and KO
siblings were crossed (WTxWT and KOxKO) to generate the
pups for this experiment in order to minimize genetic background
variations. At 4DIV, cultured neurons were treated overnight with
tetrodotoxin (TTX, 1mM; Calbiochem, La Jolla, CA), then on
DIV5 protein-DNA complexes were processed for ChIP. 4mL
purified anti-CaRF antibody (#4510)[15] was added to each
lysate (WT and KO) and incubated overnight with rotation at
4uC. For ChIP on the Carf promoter, striatum was dissected from
brains of Carf WT or KO mice and snap frozen in liquid nitrogen.
3–5 independent samples were pooled, homogenized, and
processed for ChIP as above. Immunoprecipitations were
performed at 4uC overnight with 5–10mg of each specific antibody
and assayed by real-time PCR using SYBR green detection.
Antibodies used in this study include purified normal mouse
polyclonal IgG (Millipore, Billerica, CA cat. #12-371) and anti-
RNA polymerase II, clone CTD4H8 which recognizes the largest
subunit of RNA polymerase II (Millipore, cat. #05-623). For input
samples, 25ml (6–7% of the amount used for IP with specific
antibody) was added to 75ml of elution buffer, NaCl was added to
200mM final concentration, and samples were reverse crosslinked
at 65uC overnight. All ChIP pulldowns are displayed as % of input
for each sample (WT or KO). Data presented are the result of two
independent experiments, and statistical significance was evaluat-
ed by a Student’s two-tailed unpaired t-test.
ChIP library construction and sequencing
DNA fragments coimmunoprecipitated with CaRF were
repaired using the End-It DNA End Repair Kit (Epicentre
Biotechnologies, Madison, WI), purified using the MinElute
Reaction Cleanup Kit (Qiagen, Valencia, CA) and eluted in
20ml EB buffer. The resulting DNA fragments were ligated to
adaptors for the SOLiD sequencer (Life Technologies, Carlsbad,
Neuronal Gene Targets of CaRF
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followed by purification using the MinElute Reaction Cleanup
Kit. Sequences of adaptor and barcodes can be found at http://
www.appliedbiosystems.com. The purified adaptor-ligated ChIP
DNA fragments were subject to 6% native-PAGE for In-Gel PCR
reaction. A gel slice containing 175,200bp adaptor-ligated ChIP
DNA fragments was cut and shredded. Then to add bar codes,
PCR Platinum Supermix (100,200mL, Invitrogen), 50pmol of
PCR primers containing bar codes, 0.5ml Taq DNA polymerase
(NEB), and 0.15ml Pfu Turbo DNA polymerase (Stratagene) were
added into the shredded gel slice. The adaptor-ligated ChIP DNA
fragments were amplified by 15 cycles of In-Gel PCR reactions.
After the PCR reaction, gel pieces were filtered out by 0.45mm
filter spin column and the amplified ChIP-Seq library was purified
by MinElute PCR purification kit (Qiagen). The library was
purified by one more round of 6% PAGE. A gel slice containing
200,250bp PCR products was cut and shredded, and the
amplified library was extracted out of the gel by passive elution
in elution buffer (1.5M ammonium acetate in 16TE). Gel pieces
were filtered out by filter spin column and both ChIP-Seq libraries
were purified by Qiaquick PCR purification kit (Qiagen). Samples
were affixed to a slide and sequenced on a SOLiD sequencer
version 2. After filtering with 3bp mismatches allowed in 35bp
reads, just over 5 million uniquely mapped reads (about 40% of
total reads) were obtained for each library (WT and KO). The
resulting sequences were formatted for alignment in the UCSC
genome browser.
CaRF Wildtype ChIP Peak Finding
To determine CaRF-specific binding sites, we developed an
algorithm to identify the sequences specifically enriched in the
ChIP samples from Carf WT neurons relative to the negative
control ChIP samples from Carf KO neurons. First we determined
the false detection ratio by using a sliding window with a width of
240bp for every 10bp in the mouse genome. Repetitive regions are
excluded from our analysis since it is impossible to assign 35bp
reads uniquely to such regions [20,21]. For each window, we
calculated the statistic D=R2N where R is the number of reads
in the WT sample, and N is the number of reads from the negative
control KO sample. By considering the marginal distributions of R
and N, we note that they both can be well approximated by a
Poisson distribution with parameters lR and lN, respectively. It
follows that D is a Skellam distribution [22]
Pr D~d ðÞ *Ske d;lR,lN ðÞ
~exp { lRzlN ðÞ ðÞ lR=lN ðÞ
d=2 Id(2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
lRlN
p
),
ð1Þ
where Id is the modified Bessel function of the first kind of order d.
The construction of the null distribution from Eq. (1) takes
unequal numbers of reads in the two samples into account by
shifting the mode of the distribution. To determine the number of
reads required for a 240bp window to be significant, we use the
local false detection rate (locFDR) framework [23]. Using this
methodology, we assume that the density of D, f(D), can be written
as the mixture f(D)=p0f0(D)+p1f1(D), where f0 is the null density, f1
is the density of windows corresponding to true peaks and
p0+p1=1 with p0§0.9. The locFDR, fdr(d) is related to the more
familiar FDR [24] through
FDR d ðÞ ~E½locFDR d ðÞ DD§d , ð2Þ
where E is the expectation with respect to the mixture density f.
For a fixed threshold fp=0.01 and empirically estimated
lR=0.15273 and lN=0.21607, we find that the critical difference
is d0=6 fragments. Inserting the empirical distribution and the
Skellam null distribution from Eq. (1), we find that the FDR is
,1610
27.
Motif Discovery
Regions of the genome determined to be specifically bound by
CaRF were downloaded using the GALAXY [25] platform based
on genome coordinates. Due to noise in the exact positioning of
the sequence, when significantly bound sequences were found to
be within 100bp of each other, the coordinates were expanded to
produce one larger region. In addition, very short identified
regions ( 20bp) were discarded from the analysis because these
are too short to meaningfully search for 10–15bp motifs. The
remaining 144 sequences had a mean length of 112bp, a median
of 100bp, and standard deviation of 79bp. These sequences were
fed into the PRIORITY motif finder, which uses a Gibbs sampling
strategy [26,27]. A uniform prior was used to search across CaRF
bound regions on the positive and negative strand. The default
parameters of 20 trials and 10,000 iterations per trial were used. A
third order background model was used, although the results were
robust to the use of both first and second order. Varying motif
lengths were attempted to identify the correct consensus length. At
motif lengths lower than 10bp, only a part of each motif resembled
the CaRF consensus site. At motif lengths larger than 10bp, the
information content was low at peripheral base pairs. Consistently,
a significant motif was identified with score 131. As a control, a
motif discovery was performed on the same number of sequences
with the same length, but from nearby genomic regions. The
maximum score of an identified motif in this data set over many
trials was only 15, suggesting that the motif discovered in the
CaRF ChIP-Seq data is highly significant.
Quantitative PCR
For evaluation of CaRF target gene expression, brains from
single P0 pups from a Carf heterozygote (HET6HET) cross were
removed, the cortex was dissected and rapidly frozen on liquid
nitrogen, then the thawed tissue was used for RNA harvesting. For
evaluation of Carf mRNA expression, brains from single P0 pups
from a Carf HET6HET cross were used for neuron culture as
described above. Tail biopsies were clipped during dissection and
genotyped prior to sample harvesting to identify WT and KO
pups. On day 5 in culture, RNA was harvested, and cDNA was
synthesized as above. All primers used in this analysis are listed in
Table S1. To measure Carf mRNA we used primers against exons
11–12, distal to the Carf exon 8 deletion. Samples were normalized
to Gapdh as a control for sample handling. Data shown for Carf are
the result of measurements in 8 individual pups of each genotype.
Data for other Carf target genes are the result of measurements in
4–6 individual pups of each genotype. For quantitation of
chromatin immunoprecipitation of RNA polymerase II on the
Carf gene, the primers listed in Table S1 were used to amplify a
173bp region flanking the ChIP peaks in Carf exon 1. Statistical
significance was determined by a Student’s unpaired 2-tailed t-test,
and p,0.05 was considered significant.
Results
CaRF is an evolutionarily conserved, sequence-specific
DNA binding protein
Showing that a protein domain is conserved over evolution is
one way of suggesting its importance for function of the protein.
Sequence analysis of CaRF against build 37 of the Mus musculus
Neuronal Gene Targets of CaRF
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other gene product. However we find gene products with
significant similarity to CaRF at the amino acid level in 37
different species (Table S2), including 35 vertebrates and the
deuterostome Branchiostoma floridae [28]. In all species only one
gene product with similarity to CaRF can be identified.
Interestingly, despite the absence of any gene products with
significant similarity to CaRF in the Drosophila melanogaster or
Caenorhabitas elegans genomes, a conserved CaRF ortholog is
present in the genome of the cnidarian starlet sea anemone
Nematostella vectensis, which diverged from the vertebrate lineage
over 700 million years ago [29] (Figure 1a). Sequence
Figure 1. The CaRF DNA binding domain is highly conserved across evolution. CaRF amino acid sequences were obtained from the NCBI
and Ensembl databases by BLAST similarity to mammalian CaRF (Table S2). Sequences were aligned using ClustalW. a) Phylogram representing the
evolutionary distances between CaRF sequences in six species. b) Percent identity and similarity among amino acids in each domain of CaRF. The
diagrams are drawn to scale and show four distinct domains of CaRF [14]. From left to right these are the N-terminus (corresponding to human
coding exons 1–5), the DNA binding domain and nuclear localization signal (DBD/NLS, coding exons 6–7), an intermediate domain (coding exons 8–
10), and the transcriptional activation domain (TAD, coding exons 11–14). The numbers between each pair of sequences show the percent of amino
acids within that domain that are identical/conserved between that pair within each domain. Identity and conservation of amino acids were called by
ClustalW, and insertions were scored as non-conserved amino acids. c) Sequence alignment of the DBD/NLS domain across all six species. Identical
amino acids are highlighted black, conserved amino acids are gray and nonconserved changes are white.
doi:10.1371/journal.pone.0010870.g001
Neuronal Gene Targets of CaRF
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required for DNA binding [14], in which 59% of the amino acids
are identical across species (Figure 1b,c). A second highly
conserved region aligns with amino acids 292–472 of mouse CaRF
(Figure 1b), although the functions of this domain are not known.
Because CaRF does not belong to a previously known DNA
binding domain protein family, we wanted to verify that CaRF is
capable of binding directly to DNA in the absence of other
eukaryotic cofactors. We find that His-tagged CaRF purified from
E. coli binds Bdnf CaRE1 by EMSA and is competed with the same
specificity as FLAG-tagged CaRF synthesized using a eukaryotic
in vitro transcription and translation system (Figure 2). Specif-
ically, the binding of CaRF to CaRE1 can be competed by
addition of an excess of unlabeled wildtype CaRE1 probe, but not
by the addition of a mutant CaRE1 sequence (mCaRE) that does
not support calcium-dependent Bdnf transcription [14]. These data
establish that CaRF is a conserved, sequence-specific, direct DNA
binding protein, strongly supporting its proposed role as a
transcriptional regulator.
Characterization of a high-affinity CaRF binding motif
Although we demonstrated previously that CaRF can bind the
CaRE1 element of Bdnf promoter IV [14], the full range of
sequences that can be bound by CaRF was not known. To identify
DNA sequences with high affinity for CaRF, we performed a
PCR-assisted binding site selection screen. Following four rounds
of binding site selection, EMSA analysis of the oligonucleotide
pool coimmunoprecipitated with CaRF reveals a strong CaRF-
binding band, whereas there is no significant binding to CaRF in a
control oligonucleotide pool (Figure 3a). The oligos that
coimmunoprecipitated with CaRF were cloned and sequenced,
then 62 sequences (Table S3) were aligned, revealing a 12bp
consensus CaRF binding motif (cCaRE) with the sequence 59-
YSANAACGAGGC - 39 (Y=C/T, S=C/G, and N=any base;
Figure 3b). This sequence shares significant similarity with the
CaRE1 element from the Bdnf gene (Figure 3c) strongly
supporting our previous identification of CaRF as a CaRE1
binding protein. However in competition EMSAs, CaRF shows
higher affinity for the cCaRE compared with CaRE1 (Figure 3d).
Because the cCaRE motif aligns in many of our oligos with a
sequence that was used to flank one side of the random 16mer
sequence, it is possible that our selection does not fully represent
the sequence variability that may be tolerated by CaRF.
Nonetheless, these studies indicate that the cCaRE defines a
new high affinity CaRF consensus binding site.
ChIP-Seq identifies genomic binding sites of CaRF in
neurons
Given this evidence that CaRF is a direct sequence-specific
DNA binding protein, we wanted to find endogenous gene targets
of CaRF. To identify CaRF binding sites genome-wide, we
performed chromatin immunoprecipitation with an anti-CaRF
antiserum from cultured Carf WT postnatal mouse cortical
neurons followed by sequencing of the coimmunoprecipitated
genomic DNA fragments (ChIP-Seq). Mapping these fragments to
the reference genome gives a profile of the DNA regions that are
enriched in the pulldown, however the challenge is to determine
which of the enriched regions (‘‘peaks’’) are statistically significant
at a given threshold and which correspond to the genomic
background. Thus a peak is defined as region that contains
significantly more reads from an experimental pulldown than from
a negative control. In this case, for our negative control we
performed ChIP with the same anti-CaRF antiserum from
neuronal cultures made from Carf KO mice, which are null for
Figure 2. CaRF binds DNA directly. Human CaRF was expressed in bacteria (E. Coli hCaRF) or synthesized in vitro by TNT (hCaRF). Rabbit
reticulocyte lysate without CaRF expression was used as control. 2mL of CaRF protein or TNT control was incubated with radiolabeled CaRE1 oligos in
the absence (-) or presence of a 50-fold molar excess of competing unlabeled wildtype (W) or mutant (M) CaRE1 probe. Unbound probe is at the
bottom of the gel. Arrowhead indicates the complex between CaRF and CaRE1.
doi:10.1371/journal.pone.0010870.g002
Neuronal Gene Targets of CaRF
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genomic DNA coimmunoprecipitated from the WT and KO cells,
and genomic regions specifically bound by CaRF (CaRF ChIP
peaks) were identified using the statistical algorithm described in
detail in the Methods section.
176 CaRF ChIP peaks ranging in size from 10–630bp were
identified genome-wide (Table S4). 128 of the 176 peaks (73%)
are within 10kB of an annotated gene, and 60/128 (47%) of these
are within 1kB of the annotated transcriptional start site (TSS).
Graphing the position of each of these peaks relative to the TSS
shows an enrichment in the 200bp just 59 to the TSS (Figure 4).
This positional information demonstrates a highly significant
enrichment of proximal gene promoters in the CaRF ChIP peaks
relative to their overall representation in the genome, raising the
possibility that CaRF may contribute to transcriptional regulation
of nearby genes.
Figure 3. Identification of a consensus CaRF binding element. hCaRF synthesized by TNT (hCaRF) or control rabbit reticulocyte without CaRF
(control) was used to coprecipitate oligonucleotides from a library of random 16mers. a) After four rounds of enrichment and amplification, the final
pulldown from each sample was radiolabeled and mixed with hCaRF for evaluation by EMSA. Equal amounts of radiolabeled oligos are present in
each pool (gray arrowhead), however a CaRF binding band is retarded only from the pool that was isolated by coprecipitation with hCaRF (black
arrowhead). b) WebLogo (http://weblogo.berkeley.edu/) representation of the cCaRE consensus motif derived from the 62 sequences in Table S3.
The position of the bases is indicated along the bottom from 1–16, and the height of the letters indicates the enrichment of that base at each
position. If all four bases were equally likely to be present at any position, no base is indicated. c) Alignment of the cCaRE and CaRE1 motifs. Black
indicates bases that are conserved between the elements, and gray shows bases that vary. Y=C/T, S=C/G, and N=any base. d) Comparison of the
affinity of CaRF for CaRE1 and cCaRE. A constant amount of hCaRF was bound to radiolabeled CaRE1 (B) or cCaRE (C) probes and the relative affinity
of the interactions were assessed by competition EMSA upon the addition of a 150, 100, or 50-fold molar excess of unlabeled CaRE1 probe. The band
retarded upon CaRF binding is indicated by the arrowhead.
doi:10.1371/journal.pone.0010870.g003
Neuronal Gene Targets of CaRF
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we extracted the sequences of the 176 CaRF ChIP peaks and
subjected them to analysis using the PRIORITY motif finder,
which can be used to detect statistically significant common short
sequences within a set [26,27]. 32 ChIP peaks smaller than 20bp
were eliminated from the analysis because they are too short to be
searched. This analysis found a common 10bp sequence motif in
138 of the 144 sequences examined (Table S4). The motif
extracted from this set of sequences (chCaRE) has the sequence 59-
RRARYGAGGC-39, (R=A/G, and Y=C/T) (Figure 5a). This
sequence is strikingly similar to the high affinity cCaRE (59-
YSANAACGAGGC-39) and the CaRE1 (59-CTATTTC-
GAGGC-39) CaRF binding sequences (Figure 5d), strongly
suggesting that the ChIP peak regions contain high affinity binding
sites for CaRF.
To characterize CaRF binding to the chCaRE sequences, we
first tested the ability of CaRF to bind the specific chCaRE motif
(59-AAAGCGAGGC-39) found in a CaRF ChIP peak from the
promoter of the Camk2n1 gene (camCaRE, Figure 5d). Recom-
binant CaRF binds the camCaRE as evidenced by retardation of
the radiolabeled camCaRE probe by EMSA (Figure 5b). This
association is fully competed by addition of an excess of unlabeled
camCaRE or cCaRE but not by addition of excess unlabeled
Figure 4. CaRF ChIP-Seq peaks are enriched near transcription
start sites. The ChIP peaks from Table S4 were viewed in the UCSC
genome browser (http://genome.ucsc.org) and the distance from the
center of each peak to the nearest annotated transcription start site
(TSS) was calculated. For the 60 peaks within 1kB of a TSS we tallied the
number within each 100bp. The arrow shows the position of the TSS.
doi:10.1371/journal.pone.0010870.g004
Figure 5. Identification and characterization of a conserved CaRF-binding motif in the CaRF ChIP-Seq peaks. a) WebLogo (http://
weblogo.berkeley.edu/) representation of the 10bp motif discovered by the PRIORITY motif finder in the ChIP peak sequences. The height of each
letter represents the enrichment of that base at each position. If all four bases are equally represented, no base is shown at that position. b)
Competition EMSA analysis of CaRF binding to the consensus chCaRE motif in the ChIP peak of the Camk2n1 gene (camCaRE). Arrow indicates the
CaRF-camCaRE complex, and the right triangles indicate increasing concentrations (50 or 100 fold molar excess) of the unlabeled competitor probes.
c) Competition EMSA analysis to examine the relative importance of each base across the 10bp chCaRE motif. Recombinant CaRF was incubated with
radiolabeled camCaRE in the absence (-) or presence of a 50 or 100-fold molar excess of unlabeled competitor probes. The right triangle indicates
increasing competitor concentrations. Competitor probes were based on the camCaRE sequence (AAAGCGAGGC) with the indicated changes at each
position (e.g. 1G has a G rather than an A at position 1 of the motif while the rest of the motif is unchanged). Degenerate code: Y=C/T, N=A,C,G, or T,
B=C,G, or T, R=A/G, H=A, C, or T, D=A, G, or T. d) Alignment of the cCaRE, mCaRE, chCaRE, and camCaRE sequences. The mCaRE, which fails to bind
CaRF, differs from the CaRF binding sequences at 5 positions, which are shown in gray. Degenerate bases are as described above along with S=C/G.
doi:10.1371/journal.pone.0010870.g005
Neuronal Gene Targets of CaRF
PLoS ONE | www.plosone.org 7 May 2010 | Volume 5 | Issue 5 | e10870mutant mCaRE, demonstrating sequence-specific binding of
CaRF to the camCaRE probe. Importantly, the association of
CaRF with the camCaRE is also strongly competed by a probe
representing the chCaRE motif despite the presence of degenerate
bases at positions 1,2,4, and 5.
To further understand the relative importance for CaRF
binding affinity of specific bases at each position across the
chCaRE motif, we changed each base in the camCaRE motif one
at a time and tested the ability of the changed motifs to compete
CaRF binding to camCaRE by EMSA (Figure 5c). Consistent
with the evidence that there was little sequence variability in the
chCaRE sequence at positions 3, 6, 7, and 8 (Figure 5a) switching
the base at any of these positions essentially eliminated the ability
of the altered oligo to compete the binding of CaRF to the
camCaRE (Figure 5c). These data reveal that CaRF has a strong
requirement for an A at position 3, and GAG at positions 6, 7, and
8 of the chCaRE. Changing the bases at positions 1, 9, or 10
partially impaired the ability of oligos to compete with CaRF
(Figure 5c). These data suggest CaRF has a weak requirement
for specific bases at positions 1, 9, and 10, consistent with the fact
that the preference for a specific base at these positions in the
chCaRE motif was lower than at positions 3, 6, 7, and 8
(Figure 5a). Finally, changing the bases of the camCaRE at
positions 2, 4, and 5 had a limited effect on the ability of these
oligos to compete for the binding of CaRF (Figure 5c), indicating
that CaRF has little preference for the specific bases at these
positions.
By comparing these sequence requirements at each position
across the camCaRE to the sequences of the individual chCaRE
sites identified in each of the ChIP peaks (Table S4), we estimated
the likelihood that CaRF would bind by EMSA to each individual
chCaRE motif. Strikingly, 45% of the peaks (62/138) contain a
chCaRE sequence that we predict would bind with high affinity to
CaRF, while an additional 19.5% (27/138) have sequences that
we predict would bind with lower affinity. Only 35.5% of the
chCaRE sequences (49/138) have sequences that we predict
would show no significant affinity for CaRF by EMSA. Whether
CaRF may bind to other sequence motifs in these ChIP peaks or
whether CaRF may bind these variant chCaRE motifs in
collaboration with a binding partner remains unknown. Nonethe-
less, taken together these data provide strong evidence to suggest
that the ChIP peaks represent sites of high affinity CaRF binding
to neuronal genomic DNA in vivo.
Functional analysis of CaRF ChIP targets
We next asked whether examination of the set of putative CaRF
target genes could suggest potential functions for CaRF in
neurons. Statistical analysis of the representation of Gene
Ontology (GO) terms for the genes on this list was conducted
using GOstat (http://gostat.wehi.edu.au). This analysis revealed
two statistically significant overrepresented GO categories
(Table 1). The first, proline translase activity, contained only
two genes from the list of putative CaRF targets and thus was not
considered further. By contrast, there are 15 genes from the list of
genes with CaRF ChIP peaks that fall into the second category,
phosphorous metabolism. 13 of these gene products are kinases or
phosphatases that are also included in a closely related GO
category, post-translational protein modification. This category
approached significance for overrepresentation and contained 4
additional genes from the CaRF ChIP list whose products regulate
protein ubiquitination, SUMOylation, and sulfonation. Finally, 6
of the putative CaRF target genes were not part of a defined GO
category but caught our attention for their involvement in
calcium-dependent signaling events. These genes are interesting
in light of our previous observation that the transcriptional activity
of CaRF can be modulated in a neuronal and calcium-selective
manner [14], because they suggest that CaRF may act not only
downstream, but also upstream of calcium signaling in neurons.
Taken together these data predict that CaRF may play an
important role in regulating neuronal intracellular signaling
pathways.
We observed that a CaRF ChIP peak overlaps exon 1 of the
Carf gene itself (Figure 6a), raising the possibility that, like many
other eukaryotic transcription factors [30], CaRF might regulate
its own expression. In addition to the chCaRE motif identified by
the PRIORITY motif finder, we found a second chCaRE-like site
within this ChIP peak (Figure 6b). Probes containing either of
these motifs are capable of competing the binding of recombinant
CaRF to the cCaRE in an EMSA, although the PRIORITY-
identified site has higher affinity for CaRF (Figure 6c). To test
whether CaRF might transcriptionally regulate its own expression
in vivo, we took advantage of the fact that the Carf KO mice lack
only a single exon of this gene (exon 8)[15]. Although no
functional CaRF protein is detected in the KO mice, Carf mRNA
is still transcribed. Quantitative PCR of Carf using primers distal to
the exon 8-deleted region reveal that Carf mRNA expression is
Table 1. GOstat analysis of putative CaRF targets.
GO Category Genes p value
Proline translase activity Eprs 0.00956
GO:004827 Pars2
GO:0006433
Phosphorous Metabolism Acp1 0.00956
GO: 0006783 Atp5d
GO:0006796 Atp6c0e
Dyrk2
Epha3
Epha6
Ikbke
Limk2
Map3k3
Map4k4
Mark3
Prkar1a
Ptpre
Ptprs
Srpk2
Post-translational Chst8 0.058
protein modification Fbxl20
GO: 0043687 Park2
Pias4
(also includes 13 genes from the category above)
Calcium signaling Cacng2 N/A
(not a GO category) Caly
Camk2n1
Camsap1l1
Camta1
Syt1
doi:10.1371/journal.pone.0010870.t001
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(WT=160.059, KO=1.3760.089, n=8/genotype, p=0.036;
Figure 6d). Consistent with the possibility that this enhanced
Carf RNA expression is due to increased transcription of the Carf
gene, as opposed to a change in RNA stability, we also find an
increase in RNA polymerase II association with the Carf promoter
in Carf exon 8 KO mice (WT=2.2660.06, KO=3.0560.06,
n=2/genotype, p=0.0125, Figure 6e).
To determine whether other genes that contain CaRF ChIP
peaks also show altered expression in the absence of functional
CaRF protein, we compared the expression of 13 of the genes
from Table 1 between the brains of newborn Carf WT and KO
mice (Figure 7). Expression of 8 of these gene products was
significantly different between WT and KO brains, with 4 genes
showing significantly higher expression in WT compared with
KO, while 4 showed significantly lower expression in WT
compared with KO. These data demonstrate that CaRF is
required for proper expression of a least a subset of the gene
products that neighbor the CaRF ChIP peaks.
Discussion
CaRF was first cloned in a yeast one-hybrid screen based on its
ability to bind to the CaRE1 calcium-response element of the Bdnf
gene [14]. Further characterization verified that CaRF is a nuclear
protein and that overexpression of CaRF drives CaRE1-
dependent transcription, however mapping of the domain of
CaRF required for binding to CaRE1 revealed that this region
shares no sequence homology with any known family of DNA
binding domain proteins. This was intriguing because most
transcription factors are part of large families defined by the
homology of their DNA binding domains, whereas our data
suggested that CaRF is unique.
To gain more insight into the importance of the CaRF DNA
binding domain, we first asked whether this region has been
conserved over evolutionary time. We identified conserved CaRF
orthologs from 35 vertebrates, a deuterostome, and the cnidarian
Nematostella vectensis. We did not find any evidence for CaRF
orthologs in plant genomes, suggesting that CaRF co-evolved with
the development of animal-specific functions, which include
processes such as cell-cell adhesion, cell signaling, and synaptic
transmission. Nor, intriguingly, were any orthologs identifiable in
the completed genomes of C. elegans or D. melanogaster despite the
fact that these organisms evolved after N. vectensis. The reasons for
this are unclear, although it has been observed that the genome of
N. vectensis has a gene repertoire, intron-exon structure and gene
linkage map that is more similar to that of vertebrates than to flies
or nematodes [29]. Importantly we find only one gene with any
Figure 6. CaRF regulates Carf transcription in neurons. a) Primary data from the UCSC genome browser (http://genome.ucsc.edu) showing the
CaRF ChIP peak overlapping exon 1 of the Carf gene. b) Position of CaRF-binding motifs in the CaRF ChIP peak from the Carf gene. Capital letters
denote exon 1. The underlined sequences show the two potential CaRF-binding motifs. The more 39 motif in intron 1 was identified by the PRIORITY
motif finder. c) Competition EMSA analysis demonstrates that CaRF can bind both motifs in the Carf ChIP peak. Recombinant CaRF was bound to a
radiolabeled cCaRE probe in the absence (-) or presence of a 100-fold molar excess of competitor probes. Arrow indicates the CaRF-cCaRE complex.
Unlabeled probes used as competitors are listed across the top. d) Expression of Carf mRNA in a Carf exon 8 KO mouse. Cortical neurons from
individual P0 WT or CaRF exon 8 deleted (KO) mice were cultured for 5 days, treated with 1mM TTX overnight, then RNA was harvested for cDNA
synthesis and quantitative PCR. Carf mRNA was detected with primers against exons 11–12 distal to the deleted region in Carf. Carf mRNA expression
was normalized for expression of Gapdh in the same sample to control for sample handling. e) Chromatin immunoprecipitation for RNA polymerase II
on the Carf promoter. Carf promoter DNA co-precipitated with an anti-RNA polymerase II antibody or control IgG was quantitated by Q-PCR, and
normalized as a percent of signal in the input DNA. Bars show the mean and error bars show SEM. *p,0.05.
doi:10.1371/journal.pone.0010870.g006
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unlikely to be part of a larger transcription factor family. By
aligning these sequences, we show that the DNA binding domain
of CaRF has been highly conserved across hundreds of millions of
years of evolution, strongly suggesting that CaRF has a conserved
function as a DNA binding protein. Given our evidence that
CaRF binds directly to DNA, and the fact that DNA binding
domains are otherwise some of the best understood protein
structures, it will of great interest in the future to determine the
structure of the CaRF DNA binding sequence to understand this
novel domain.
We took two complementary approaches to identifying CaRF
binding sites. First we conducted a PCR-assisted binding site
selection screen in vitro which identified a 12bp high-affinity
CaRF-binding motif (cCaRE). In an independent set of
experiments, we identified a highly similar motif (the 10bp
chCaRE) when we aligned the fragments of neuronal genomic
DNA that specifically coimmunoprecipitated with CaRF by
ChIP. The chCaRE motif was found in 78% of the 176 CaRF
ChIP peaks, and by testing the requirement for each degenerate
base across the chCaRE motif we provide evidence that CaRF is
likely to show affinity for at least 64.5% of the variant chCaRE
motifs in vitro. These data raise the question of whether CaRF also
directly associates with the other 35.5% of the ChIP peaks that
contain base changes in key positions within the chCaRE motif,
as well as those that lack a sequence with any similarity to the
cCaRE.
Transcription factors vary in their requirement for a consensus
motif to guide their selection of genomic binding sites [5]. For
example, consensus binding motifs are highly enriched in genomic
binding sites for the transcriptional repressor REST [7], whereas
other factors, including the neuronal activity-regulated transcrip-
tion factor CREB, are frequently found bound to regions that lack
a consensus binding sequence [8]. In the case of CaRF, one
possibility is that in addition to cCaRE-like sequences, CaRF may
directly bind additional distinct sequence motifs that were not
identified in our binding site selection screen. A recent
comprehensive analysis of DNA binding preferences conducted
for a large group of transcription factors revealed that approxi-
mately half of these factors recognized multiple distinct sequence
motifs, indicating that DNA binding preferences of transcription
factors may be more flexible than previously realized [31]. It is also
possible that the association of CaRF with peaks that lack
consensus binding sites is indirect. Protein-protein interactions can
recruit transcription factors to regions that lack consensus binding
motifs either through an association that depends solely on the
binding of the interacting factor to DNA, or by cooperative
binding between the transcription factor of interest and the
interacting factor in a manner that changes the affinity of the
transcription factor for non-consensus DNA motifs [5]. It would be
particularly interesting if CaRF were recruited to consensus and
non-consensus binding sites through distinct mechanisms, as this
would imply a potential means to differentially regulate the
expression of subsets of CaRF target genes.
GOstat analysis of the genes that neighbor the CaRF ChIP
peaks revealed overrepresentation of gene products involved in
signaling pathways, suggesting the possibility that CaRF-depen-
dent transcription may modulate intracellular states in neurons.
Interestingly, the known functions of these gene products suggest
possible mechanisms through which CaRF could contribute to
experience-dependent synaptic development and plasticity. For
example the Eph family receptor tyrosine kinases Epha3 and Epha6
are regionally expressed in the developing brain, where they play
important roles in neural patterning [32]. Within the visual
system, EphA signaling has been shown to cooperate with neural
activity in the refinement of the synaptic connections that are
required for the establishment of topographic maps in both the
thalamus and the visual cortex during development [33,34]. In
Figure 7. Altered expression of a subset of the putative CaRF target genes in Carf knockout mice. RNA from P0 cortex of Carf WT or KO
was processed for quantitative PCR using primers against a subset of the putative CaRF target genes. In each case, mRNA expression was normalized
for expression of Gapdh in the same sample to control for sample handling. Data are displayed as expression in KO brains relative to expression in WT
brains. A value of 1 indicates no difference in expression, whereas values less than 1 indicate reduced expression in KO compared with WT, and values
greater than 1 indicate increased expression in KO compared with WT. n=4–6 for each genotype. Bars show the mean and error bars represent S.E.M.
*p,0.05 for KO compared with WT.
doi:10.1371/journal.pone.0010870.g007
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calcium signaling, the proteins encoded by Caly (Calcyon) and
Cacng2 (Stargazin) contribute to the regulation of AMPA-type
glutamate receptor trafficking to synapses [35,36] suggesting a
possible mechanism by which CaRF-dependent transcription
could modulate the strength of excitatory synapses. These data
are particularly exciting in light of our findings that adult Carf KO
mice show abnormalities in several tests of learning and memory
[15]. Specifically these mice display impaired extinction of
context-dependent fear conditioning as well as reduced remote
memory retention in a novel object recognition task. Performance
in both of these memory tests is thought to depend on experience-
dependent changes in cortical synaptic function [37,38]. Whether
activity-dependent plasticity of glutamatergic synapses is altered in
the Carf knockout mice, and whether any the gene products
identified in this study contribute to the memory phenotypes in
these mice, will be interesting questions to explore.
Despite the evidence for the enrichment of functional pathways
among the putative CaRF targets, it remains possible that our list
of genomic CaRF binding sites is incomplete. To ensure the
specificity of ChIP using the anti-CaRF antibody, we sequenced
ChIP libraries made from both Carf WT and KO neurons then
developed a statistical method to identify only those genomic
regions significantly enriched in the pulldown from the WT cells.
This method of analysis yielded a relatively small number of peaks
compared with other genome-scale ChIP studies [7,39,40],
suggesting that by setting our parameters to define a stringent
threshold for peak detection we may have increased the likelihood
of false negatives. For example, we did not find a CaRF ChIP peak
in promoter IV of the Bdnf gene, which could indicate either that
CaRF was not bound to Bdnf CaRE1 under the conditions used in
this study or that this interaction was undetectable for technical
reasons. In addition, despite the evidence that the transcriptional
activity of CaRF can be acutely enhanced by the activation of L-
type voltage gated calcium channels in neurons [14], we did not
find extensive overlap between the list of putative CaRF target
genes (Table S4) and several large published sets of neuronal
activity-dependent genes [19,41,42].
Nonetheless, we have demonstrated that at least a subset of the
putative CaRF target genes show altered expression in the brains
of Carf KO mice, demonstrating that CaRF expression is
important for their proper regulation. It is interesting that whereas
in heterologous overexpression assays CaRF acts as a CaRE1-
dependent transcriptional activator of a Bdnf promoter IV-
luciferase reporter [14], the data presented in Figure 6d and
Figure 7 demonstrate both up- and down-regulation of genes
with CaRF ChIP peaks in the Carf KO mice. Although loss of
CaRF may indirectly elevate gene expression, because the genes
we have assayed here directly neighbor sites of CaRF binding in
vivo, these data raise the possibility that CaRF acts as a direct
repressor of a subset of its target genes. The functions of many
transcriptional regulators are highly context dependent, and can
be influenced by cell type [43], post-translational modifications
[44,45], protein-protein interactions [46], as well as the local
chromatin environment [47]. The molecular mechanisms by
which CaRF regulates transcription are not fully understood,
however our previous overexpression experiments indicated that
the C-terminal region of CaRF was required for its ability to
activate the Bdnf promoter IV reporter plasmid [14]. In this
context it is interesting that in addition to producing full-length
Carf transcripts, we have found that the Carf locus also encodes a
C-terminally truncated Carf variant through the use of an
alternative polyadenylation site in the intron just following the
exons that encode the DNA binding domain [15]. This variant is
expressed in brain and is predicted to bind DNA but not to
activate transcription. Thus the short variant of CaRF could
potentially act as an endogenous dominant negative of CaRF-
dependent transcription. Our antibody was raised against the
complete CaRF protein and will immunoprecipitate both forms of
CaRF, and importantly both the short and the long variants of
CaRF are absent in our KO mice [15]. However whether different
CaRF variants are recruited differentially to different regions of
the genome, and whether either form of CaRF can actively repress
transcription remains to be tested. In conclusion, by continuing to
combine the analysis of gene expression in our Carf KO mouse
with the identification of genomic binding sites of CaRF presented
here we expect these data will provide a crucial starting point for a
detailed study of the molecular mechanisms that regulate CaRF-
dependent transcription in neurons.
Supporting Information
Table S1 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.pone.0010870.s001 (0.07 MB
DOC)
Table S2 CaRF orthologs. CaRF orthologs were identified by
BLAST search for translated nucleotide sequences with high
similarity to Mus musculus CaRF. Orthologs from 37 species were
identified, and accession numbers are listed below. ENS sequences
are from Ensembl (http://www.ensembl.org) and XM, XR, and
NR sequences are from NCBI (http://www.ncbi.nlm.nih.gov/
entrez).
Found at: doi:10.1371/journal.pone.0010870.s002 (0.04 MB
DOC)
Table S3 Identification of a high affinity CaRF binding motif by
PCR-assisted site selection. Oligos selected after four rounds of
coimmunoprecipitation with CaRF were cloned in the vector
pBluescript and sequenced. 62 sequences were aligned and the
best fitted 16bp motif is shown for each clone. Capital letters
indicate bases within the random 16mer sequence and lower case
letters indicate the flanking sequences.
Found at: doi:10.1371/journal.pone.0010870.s003 (0.04 MB
DOC)
Table S4 Genomic locations of CaRF ChIP peaks and
identification of a conserved in vivo CaRF binding motif. Peak
files derived from the CaRF ChIP were loaded into the UCSC
browser to analyze genomic location. Location denotes the
chromosomal position of each peak. The peak start and end
numbers are in reference to build 37 of the Mus musculus genome
(mm9, July 2007; http://genome.ucsc.edu). The nearest annotated
gene within 10kB of the ChIP peak is listed under Gene Symbol.
The Motif column shows the sequence of the common 10bp motif
found by PRIORITY analysis of the ChIP peak sequences. The
sequences not included in the analysis are marked ‘‘too short’’, and
sequences analyzed that did not contain a conserved motif are
marked ‘‘none.’’ Finally based on in vitro analysis of CaRF’s
tolerance for base pair changes across the motif as shown in
Figure 5c, we predicted the affinity of CaRF for each of the motif
sequences by EMSA. Motifs with base pair changes in positions 3,
6, 7, or 8 are denoted as ‘‘Low’’ affinity, motifs with base pair
changes in positions 1, 9, or 10 are denoted ‘‘Medium’’ affinity,
and the remaining motifs are ‘‘High’’ affinity. The 60 peaks
highlighted in gray are within 1kB of a transcriptional start site and
were used for the positional analysis of CaRF binding sites in
Figure 4.
Found at: doi:10.1371/journal.pone.0010870.s004 (0.27 MB
DOC)
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